We report two cases of cerebral venous sinus thrombosis associated with an antibody to phospholipids, namely the lupus anticoagulant. Both patients later developed further immunologically mediated conditions. The importance of screening for the lupus anticoagulant in addition to anticardiolipin antibodies in this condition and the need for follow-up of such patients is discussed.
The association of antiphospholipid antibodies with thrombotic episodes is well established. In the absence of other connective tissue disease such an association is known as the primary antiphospholipid syndrome.' In clinical practice antiphospholipid antibodies may be detected by one of two methods. In plasma, by prolongation of clotting time in phospholipiddependent tests, this being termed the 'lupus anticoagulant', or in serum, where anticardiolipin antibodies are detected by immunoassay. These methods identify different members of a group of antibodies with varying specificities for phospholipid (see figure 1) .
Cerebral venous sinus thrombosis is associated with hypercoaguable states and a number of immune-mediated conditions.2 Reports of cerebral venous sinus thrombosis with antiphospholipid antibodies are, however, limited.' We hereby report two such cases, both presenting with isolated raised intracranial pressure. The implications oftheir presentation, investigative findings and follow-up are discussed.
Case 1
A 30-year-old man was admitted with a twoweek history of morning headache, nausea and vomiting. Over the second week he had noted a deterioration in visual acuity in both eyes. Eighteen months prior to this admission he had been investigated for a monoarthropathy of the right knee. At that time his erythrocyte sedimentation rate (ESR) was elevated at 48; rheumatoid factor (RF) was negative. Eight figure 2 ). An auto-antibody screen (antinuclear factor (ANF), dsDNA, ANCA, RF, ENA and anticardiolipin) was negative. Partial thromboplastin time (PTT) was elevated at 1.2 s (normal 0.93-1.17), platelet count was normal. A prothrombotic screen showed normal levels of protein C, S and antithrombin III. The lupus anticoagulant was positive (as determined by the Exner and Russell Viper Venom methods).
INTRINSIC
The patient improved symptomatically with lumbar puncture, oral steroids and acetazolamide. In view of recurrent thrombotic episodes and a positive lupus anticoagulant a presumptive diagnosis ofprimary antiphospholipid syndrome was made and he was anticoagulated. Over four weeks his symptoms resolved, visual acuity returned to normal and fundal appearances settled.
Four months later he represented with oral and genital ulceration in association with a vasculitic rash on the left shin and reactivation of the right knee arthropathy. Biopsy of the rash revealed a fibrinoid vasculitis consistent with a diagnosis of Behcet's disease.
Case 2
A 42-year-old woman presented with three weeks of constant headache and vomiting. She had noted intermittent blurring of vision in the right eye which was worse when standing. She had undergone stripping of varicose veins six weeks previously.
General examination was normal. Neurological examination showed bilateral, nonhaemorrhagic papilloedema with retained visual acuity (6/6 bilaterally The first patient had a past history suggestive both of a prothrombotic tendency and a possible immunologically mediated arthropathy. Subsequently he developed Behcet's disease, an independent risk factor for cerebral venous sinus thrombosis6 and previously described in association with antiphospholipid antibodies. In the second patient, sigmoid sinus thrombosis occurred six weeks after varicose vein surgery. Though cerebral venous sinus thrombosis has been described post operatively this is generally in the immediate postoperative period. The later presentation with an immunologically mediated skin disorder and lupus anticoagulant indicate this to be the probable specific causative agent. In both patients the marginal prolongation of PTT at presentation suggests the presence of a circulating anticoagulant.
In our patients it is notable that a full auto-antibody screen, including anticardiolipin and ANF, was negative and in patient 2 inflammatory markers were not raised. The prolongation of PTT or thrombocytopenia may not always be found in these patients and the presence ofthe lupus anticoagulant may not therefore be suspected. It is important to recognise that though both the lupus anticoagulant and anticardiolipin antibodies are often present in an individual (70% concordance), each may be present in isolation, as in these two patients.
Both patients presented with symptoms and signs of raised intracranial pressure and had normal CT head scans. Such findings are characteristic of the syndrome of benign intracranial hypertension, though both patients would have been atypical for such a diagnosis in terms of age and build. The chronic presentation of cerebral venous sinus thrombosis may mimic benign intracranial hypertension, CT head scans are often normal in these patients, and this diagnosis should be considered in cases of benign intracranial hypertension occurring in patients not obviously at risk for this condition. The investigation of choice in this situation is now MRI and MRI angiography. These two cases demonstrate the importance of screening for anLiphospholipid antibodies in patients presenting with cerebral venous sinus thrombosis. In patients where such antibodies are identified clinicians should be aware not only of the risk of recurrent thrombosis but also of the possible later development of associated immunologically mediated conditions.
